| Autor: |
Cuenca I; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Botella C; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Moya-Quiles MR; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Jimenez-Coll V; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Galian JA; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Martinez-Banaclocha H; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Muro-Pérez M; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Minguela A; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Legaz I; Department of Legal and Forensic Medicine, Biomedical Research Institute of Murcia (IMIB), Regional Campus of International Excellence 'Campus Mare Nostrum', Faculty of Medicine, University of Murcia (UMU), 30100 Murcia, Spain., Muro M; Immunology Service, University Clinical Hospital 'Virgen de la Arrixaca', Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain. |
| Abstrakt: |
Alpha-1 antitrypsin (AAT1) deficiency (AAT1D) is an inherited disease with an increased risk of chronic obstructive pulmonary disease (COPD), liver disease, and skin and blood vessel problems. AAT1D is caused by mutations in the SERPINE1 gene (Serine Protease Inhibitor, group A, member 1). Numerous variants of this gene, the Pi system, have been identified. The most frequent allelic variants are Pi*M, Pi*S, and Pi*Z. The development of COPD requires both a genetic predisposition and the contribution of an environmental factor, smoking being the most important. Studies on this deficiency worldwide are very scarce, and it is currently considered a rare disease because it is underdiagnosed. The aim of this study was to analyze the genotypic frequencies of mutations associated with AAT1 deficiency in unrelated bone marrow donors from the donor registry of the Region of Murcia in southeastern Spain due to the high risk of presenting with different pathologies and underdiagnosis in the population. A total of 112 DNA-healthy voluntary unrelated bone marrow donors from different parts of the Region of Murcia were analyzed retrospectively. AAT1 deficiency patient testing involved an automated biochemical screening routine. The three main variants, Pi*M, Pi*Z, and Pi*S, were analyzed in the SERPINE1 gene. Our results showed a frequency of 3.12% of the Pi*Z (K342) mutation in over 224 alleles tested in the healthy population. The frequency of Pi*S (V264) was 11.1%. The frequency of the haplotype with the most dangerous mutation, EK342 EE264, was 4.46%, and the frequency of EK342 EV264 was 1.78% in the healthy population. Frequencies of other EE342 EV264-mutated haplotypes accounted for 18.7%. As for the EE342 VV264 haplotype, 0.89% of the total healthy population presented heterozygous for the EV264 mutation and one individual presented homozygous for the VV264 mutation. In conclusion, the frequencies of Pi mutations in the healthy population of the Region of Murcia were not remarkably different from the few studies reported in Spain. The genotype and haplotype frequencies followed the usual pattern. Health authorities should be aware of this high prevalence of the Pi*S allelic variant and pathological genotypes such as Pi*MZ and Pi*SZ in the healthy population if they consider screening the smoking population. |
